The evil axis of obesity, inflammation and type-2 diabetes

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 11, Issue 1, 2011, Pages 23-31

  Das, Arghya ^a   Mukhopadhyay, Sangita ^a  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

Author keywords

Adipokines; Inflammation; Macrophages adipocytes; Obesity; Signal transduction; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPOKINETIC HORMONE; ADIPONECTIN; ANGIOTENSINOGEN; ANTIDIABETIC AGENT; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FATTY ACID; GLUTATHIONE DISULFIDE; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; LISOFYLLINE; MACROPHAGE MIGRATION INHIBITION FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE GROWTH FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; RESISTIN; S6 KINASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL FATE; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM; FATTY ACID OXIDATION; GENE DISRUPTION; HEALTH HAZARD; HORMONE RELEASE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PROTEIN SECRETION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION;

EID: 79953015077     PISSN: 18715303     EISSN: None     Source Type: Journal    
DOI: 10.2174/187153011794982086     Document Type: Review

References (97)

1. Zhang, X.; Zhang, G.; Zhang, H.; Karin, M.; Bai, H. and Cai, D. (2008) Hypothalamic IKKβ/NF-κB and ER stress link overnutrition to energy imbalance and obesity. Cell, 135, 61-73.
2. Gauthier, M.S. and Ruderman, NB. (2010) Adipose tissue inflammation and insulin resistance: all obese humans are not created equal. Biochem. J., 430, e1-4.
3. Das, U.N. (2002) Obesity, metabolic syndrome X, and inflammation. Nutrition, 18, 430-432.
4. Herder, C.; Schneitler, S.; Rathmann, W.; Haastert, B.; Schneitler, H.; Winkler, H.; Bredahl, R.; Hahnloser, E. and Martin, S. (2007) Low-grade inflammation, obesity, and insulin resistance in adolescents. J. Clin. Endocrinol. Metab., 92, 4569-4574.
5. Lazar MA. (2005) How obesity causes diabetes: not a tall tale. Science, 307, 373-375.
6. Kim, J.K. (2010) Inflammation and insulin resistance: an old story with new ideas. Korean Diabetes J., 34, 137-145.
7. Schmidt, M.I.; Duncan, B.B.; Sharrett, A.R.; Lindberg, G.; Savage, P.J.; Offenbacher, S.; Azambuja, M.I.; Tracy, R.P. and Heiss, G. (1999) Markers of inflammation and prediction of diabetes mellitus in adults [Atherosclerosis Risk in Communities study]: a cohort study. Lancet, 353, 1649-1652.
8. Kahn, S.E.; Hull, R.L. and Utzschneider, K.M. (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444, 840-846.
9. Whitmore, C. (2010) Type 2 diabetes and obesity in adults. Br. J. Nurs., 19, 882-886.
10. Sazonov, E.S. and Schuckers, S. (2010) The energetics of obesity: a review: monitoring energy intake and energy expenditure in humans. IEEE Eng. Med. Biol. Mag., 29, 31-35.
11. Solinas, G.; Vilcu, C.; Neels, J.G.; Bandyopadhyay, G.K.; Luo, J.L.; Naugler, W.; Grivennikov, S; Wynshaw-Boris, A; Scadeng, M; Olefsky, J.M. and Karin, M. (2007) JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab., 6, 386-397.
12. Kursawe, R.; Eszlinger, M.; Narayan, D.; Liu, T.; Bazuine, M.; Cali, AM.; D'Adamo, E.; Shaw, M.; Pierpont, B.; Shulman, G.I.; Cushman, S.W.; Sherman, A. and Caprio, S. (2010) Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis. Diabetes, 59, 2288-2296.
13. Kawazoe, Y.; Naka, T.; Fujimoto, M.; Kohzaki, H.; Morita, Y.; Narazaki, M.; Okumura, K.; Saitoh, H; Nakagawa, R.; Uchiyama, Y.; Akira, S. and Kishimoto, T. (2001) Signal transducer and activator of transcription [STAT]-induced STAT inhibitor 1 [SSI-1]/suppressor of cytokine signalling 1 [SOCS1] inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 [IRS-1] phosphorylation. J. Exp. Med., 193, 263-269.
14. Sewter C.; Berger, D.; Considine, R.V.; Medina, G.; Rochford, J.; Ciaraldi, T.; Henry, R.; Dohm, L.; Flier J.S.; O'Rahilly, S. and Vidal-Puig, A.J. (2002) Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-α. Diabetes, 51, 1035-1041.
15. Ducluzeau, P.H.; Perretti, N.; Laville, M.; Andreelli, F.; Vega, N.; Riou, J.P. and Vidal, H. (2001) Regulation by insulin of gene expression in human skeletal muscle and adipose tissue: evidence for specific defects in type 2 diabetes. Diabetes, 50, 1134-1142.
16. Kim, J.B.; Sarraf, P.; Wright, M.; Yao, K.M.; Mueller, E.; Solanes, G.; Lowell, B.B. and Spiegelman, B.M. (1998) Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J. Clin. Invest., 101, 1-9.
17. Moller, D.E. and Flier, J.S. (1991) Insulin resistance--mechanisms, syndromes, and implications. N. Engl. J. Med., 325, 938-948.
18. Price, S.R.; Olivecrona, T. and Pekala, P.H. (1986) Regulation of lipoprotein lipase synthesis by recombinant tumor necrosis factorthe primary regulatory role of the hormone in 3T3-L1 adipocytes. Arch. Biochem. Biophys., 251, 738-746.
19. Grunfeld, C. and Feingold, K.R. (1991) The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy, 3, 143-158.
20. Hotamisligil, G.S.; Spiegelman, B.M. Treatment of insulin resistance in obesity linked type II diabetes using antagonists to TNFalpha function. U.S. Patent 6015558, January 8, 2000. (http://www.freepatentsonline.com/6015558.html)
21. S.M. (2003) Insulin resistance, inflammation, and the prediabetic state. Am. J. Cardiol., 92, 18J-26J.
22. Monteiro, R. and Azevedo, I. (2010) Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm., [Epub ahead of print].
23. Su, D.; Coudriet, G.M.; Hyun Kim, D.; Lu, Y.; Perdomo, G.; Qu, S.; Slusher, S.; Tse, H.M.; Piganelli, J.; Giannoukakis, N.; Zhang, J. and Dong, H. (2009) FoxO1 links insulin resistance to proinflammatory cytokine IL-1β production in macrophages. Diabetes, 58, 2624-2633.
24. Ghanim, H.; Aljada, A.; Hofmeyer, D.; Syed, T.; Mohanty, P. and Dandona, P. (2004) Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation, 110, 1564-1571.
25. Yudkin, J.S.; Stehouwer, C.D.; Emeis, J.J. and Coppack, S.W. (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol., 19, 972-978.
26. Mohamed-Ali, V.; Goodrick, S.; Rawesh, A.; Katz D.R.; Miles, J.M.; Yudkin, J.S.; Klein, S. and Coppack, S.W. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J. Clin. Endocrinol. Metab., 82, 4196-4200.
27. Lundgren, C.H.; Brown, S.L.; Nordt, T.K.; Sobel, B.E. and Fujii, S. (1996) Elaboration of type-1 plasminogen activator inhibitor from adipocytes: a potential pathogenetic link between obesity and cardiovascular disease. Circulation, 93, 106-110.
28. Weisberg, S.P.; McCann, D.; Desai, M.; Rosenbaum, M.; Leibel, R.L. and Ferrante, A.W. Jr. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest., 112, 1796-1808.
29. Galic, S.; Oakhill, J.S. and Steinberg, G.R. (2010) Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol., 316, 129-139.
30. Kershaw, E.E. and Flier, J.S. (2004) Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab., 89, 2548-2556.
31. Gustafson, B. (2010) Adipose tissue, inflammation and atherosclerosis. J. Atheroscler. Thromb., 17, 332-341.
32. Antuna-Puente, B.; Feve, B.; Fellahi, S. and Bastard, J.P. (2008) Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab., 34, 2-11.
33. Yang, W.S.; Lee, W.J.; Funahashi, T.; Tanaka, S.; Matsuzawa, Y.; Chao, C.L.; Chen, C.L.; Tai, T.Y. and Chuang, L.M. (2001) Weight reduction increases plasma levels of an adipose-derived antiinflammatory protein, adiponectin. J. Clin. Endocrinol. Metab., 86, 3815-3819.
34. Ceddia, R.B.; William, W.N. Jr.; Lima, F.B.; Flandin, P.; Curi, R. and Giacobino, J.P. (2000) Leptin stimulates uncoupling protein-2 mRNA expression and Krebs cycle activity and inhibits lipid synthesis in isolated rat white adipocytes. Eur. J. Biochem., 267, 5952-5958.
35. Shimabukuro, M.; Koyama, K.; Chen, G.; Wang, M.Y.; Trieu, F.; Lee, Y.; Newgard, C.B. and Unger, R.H. (1997) Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci., 94, 4637-4641.
36. Tzanavari, T.; Giannogonas, P. And Karalis, K.P. (2010) TNF-α and obesity. Curr. Dir. Autoimmun., 11, 145-156.
37. Peraldi, P. and Spiegelman, B. (1998) TNF-α and insulin resistance: summary and future prospects. Mol. Cell. Biochem., 182, 169-175.
38. Tanaka, T.; Itoh, H.; Doi, K.; Fukunaga, Y.; Hosoda, K.; Shintani, M.; Yamashita, J.; Chun, T.H.; Inoue, M.; Masatsugu, K.; Sawada, N.; Saito, T.; Inoue, G.; Nishimura, H.; Yoshimasa, Y. and Nakao, K. (1999) Down regulation of peroxisome proliferator-activated receptor gamma expression by inflammatory cytokines and its reversal by thiazolidinediones. Diabetologia, 42, 702-710.
39. Wu, H.; Ghosh, S.; Perrard, X.D.; Feng, L.; Garcia, G.E.; Perrard, J.L.; Sweeney, J.F.; Peterson, L.E.; Chan, L.; Smith, C.W. and Ballantyne, C.M. (2007) T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation, 115, 1029-1038.
40. Appay, V. and Rowland-Jones, S.L. (2001) RANTES: a versatile and controversial chemokine. Trends Immunol., 22, 83-87.
41. Keophiphath, M.; Rouault, C.; Divoux, A.; Clément, K. and Lacasa, D. (2010) CCL5 promotes macrophage recruitment and survival in human adipose tissue. Arterioscler. Thromb. Vasc. Biol., 30, 39-45.
42. Maghazachi, A.A.; Al-Aoukaty, A. and Schall, T.J. (1996) CC chemokines induce the generation of killer cells from CD56+ cells. Eur. J. Immunol., 26, 315-319.
43. Charbonneau, A. and Marette, A. (2010) Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice: potential role of tyrosine nitration of insulin signaling proteins. Diabetes, 59, 861-871.
44. Noronha, B.T.; Li, J.M.; Wheatcroft, S.B.; Shah, A.M. and Kearney, M.T. (2005) Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity. Diabetes, 54, 1082-1089.
45. Holcomb, I.N.; Kabakoff, R.C.; Chan, B.; Baker, T.W.; Gurney, A.; Henzel, W.; Nelson, C.; Lowman, H.B.; Wright, B.D.; Skelton, N.J.; Frantz G.D.; Tumas, D.B.; Peale, F.V. Jr.; Shelton, D.L. and Hébert, C.C. (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J., 19, 4046-4055.
46. Gerstmayer, B.; Küsters, D.; Gebel, S.; Müller, T.; Van Miert, E.; Hofmann, K. and Bosio, A. (2003) Identification of RELMγ, a novel resistin-like molecule with a distinct expression pattern. Genomics, 81, 588-595.
47. Barnes, K.M. and Miner, J.L. (2009) Role of resistin in insulin sensitivity in rodents and humans. Curr. Protein Pept. Sci., 10, 96-107.
48. Youn, B.S.; Yu, K.Y.; Park, H.J.; Lee, N.S.; Min, S.S.; Youn, M.Y.; Cho, Y.M.; Park, Y.J.; Kim, S.Y.; Lee, H.K. and Park, K.S. (2004) Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab., 89, 150-156.
49. Gharibeh, M.Y.; Al Tawallbeh, G.M.; Abboud, M.M.; Radaideh, A.; Alhader, A.A. and Khabour, O.F. (2010) Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients. Diabetes Metab., [Epub ahead of print].
50. Asensio, C.; Cettour-Rose, P.; Theander-Carrillo, C.; Rohner-Jeanrenaud, F. and Muzzin P. (2004) Changes in glycemia by leptin administration or high- fat feeding in rodent models of obe sity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis. Endocrinology, 145, 2206-2213.
51. Xu, H.; Barnes, G.T.; Yang, Q.; Tan, G.; Yang, D.; Chou, C.J.; Sole, J.; Nichols, A.; Ross, J.S.; Tartaglia, L.A. and Chen, H. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest., 112, 1821-1830.
52. Hotamisligil, G.S. (1999) The role of TNFα and TNF receptors in obesity and insulin resistance. J. Intern. Med., 245, 621-625.
53. Silswal, N.; Singh, A.K.; Aruna, B.; Mukhopadhyay, S.; Ghosh, S. and Ehtesham, N.Z. (2005) Human resistin stimulates the proinflammatory cytokines TNF-α and IL-12 in macrophages by NF-κB-dependent pathway. Biochem. Biophys. Res. Commun., 334, 1092-1101.
54. Ghosh, S.; Singh, A.K.; Aruna, B.; Mukhopadhyay, S. and Ehtesham, N.Z. (2003) The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications. Gene, 305, 27-34.
55. Lumeng, C.N.; Bodzin, J.L. and Saltiel, A.R. (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest., 117, 175-184
56. Shelton, R.C. and Miller, A.H. (2010) Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog. Neurobiol., 91, 275-299.
57. Trayhurn, P. and Wood, I.S. (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr., 92, 347-355.
58. Frayn, K.N.; Karpe, F.; Fielding, B.A.; Macdonald, I.A. and Coppack, S.W. (2003) Integrative physiology of human adipose tissue. Int. J. Obes. Relat. Metab. Disord., 27, 875-888.
59. Zhang, X.; Lam, K.S.; Ye, H.; Chung, S.K.; Zhou, M.; Wang, Y. and Xu, A. (2010) Adipose tissue-specific inhibition of hypoxia inducible factor 1α induces obesity and glucose intolerance by impeding energy expenditure in mice. J. Biol. Chem., [Epub ahead of print].
60. Semenza, G.L. (2001) HIF-1 and mechanisms of hypoxia sensing, Curr. Opin. Cell Biol., 13, 167-171.
61. Lolmède, K.; Durand de Saint Front, V.; Galitzky, J.; Lafontan, M. and Bouloumié, A. (2003) Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int. J. Obes. Relat. Metab. Disord., 27, 1187-1195.
62. Ye, J. (2009) Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int. J. Obes., 33, 54-66.
63. Solinas, G. and Karin, M. (2010) JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction. FASEB J., 24, 2596-2611.
64. Howard, J.K. and Flier, J.S. (2006) Attenuation of leptin and insulin signalling by SOCS proteins. Trends Endocrinol. Metab., 17, 365-371.
65. Ghanim, H.; Abuaysheh, S.; Sia, C.L.; Korzeniewski, K.; Chaudhuri, A.; Fernandez-Real J.M. and Dandona, P. (2009) Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signalling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care, 32, 2281-2287.
66. Rui, L.; Yuan, M.; Frantz, D.; Shoelson, S. and White, M.F. (2002) SOCS-1 and SOCS-3 block insulin signalling by ubiquitinmediated degradation of IRS1 and IRS2. J. Biol. Chem., 277, 42394-42398.
67. Ozcan, U.; Cao, Q.; Yilmaz, E.; Lee, A.H.; Iwakoshi, N.N.; Ozdelen, E.; Tuncman, G.; Görgün, C.; Glimcher, L.H. and Hotamisligil, G.S. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science, 306, 457-461.
68. Hotamisligil, G.S. (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell, 140, 900-917.
69. Alhusaini, S.; McGee, K.; Schisano, B.; Harte, A.; McTernan, P.; Kumar, S. and Tripathi, G. (2010) Lipopolysaccharide, high glucose and saturated fatty acids induce endoplasmic reticulum stress in cultured primary human adipocytes: Salicylate alleviates this stress. Biochem. Biophys. Res. Commun., 397, 472-478.
70. Tzatsos, A. and Kandror K.V. (2006) Nutrients suppress phosphatidylinositol 3-kinase/Akt signalling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol. Cell. Biol., 26, 63-76.
71. Tremblay, F.; Jacques, H. and Marette, A. (2005) Modulation of insulin action by dietary proteins and amino acids: role of the mammalian target of rapamycin nutrient sensing pathway. Curr. Opin. Clin. Nutr. Metab. Care, 8, 457-462.
72. Tremblay, F.; Gagnon, A.; Veilleux, A.; Sorisky, A. and Marette, A. (2005) Activation of the mammalian target of rapamycin pathway acutely inhibitsinsulin signalling to Akt and glucose transport in 3T3-L1 and human adipocytes. Endocrinology, 146, 1328-1337.
73. Um, S.H.; D'Alessio, D. and Thomas, G. (2006) Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab., 3, 393-402.
74. Ost, A.; Svensson, K.; Ruishalme, I.; Brännmark, C.; Franck, N.; Krook, H.; Sandström, P.; Kjolhede, P. and Strålfors, P. (2010) Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes. Mol. Med., 16, 235-246.
75. Ju, J.S.; Gitcho, M.A.; Casmaer, C.A.; Patil, P.B.; Han, D.G.; Spencer, S.A. and Fisher, J.S. (2007) Potentiation of insulinstimulated glucose transport by the AMP-activated protein kinase. Am. J. Physiol. Cell Physiol., 292, C564-C572.
76. Carling, D. (2004) The AMP-activated protein kinase cascade--a unifying system for energy control. Trends Biochem. Sci., 29, 18-24.
77. Pilon, G.; Dallaire, P. and Marette A. (2004) Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs. J. Biol. Chem., 279, 20767-20774.
78. Chavey, C.; Lazennec, G.; Lagarrigue, S.; Clapé C.; Iankova, I.; Teyssier, J.; Annicotte, J.S.; Schmidt, J; Mataki, C.; Yamamoto, H.; Sanches, R.; Guma, A.; Stich, V.; Vitkova, M.; Jardin-Watelet, B.; Renard, E.; Strieter, R.; Tuthill, A.; Hotamisligil, G.S.; Vidal-Puig, A.; Zorzano, A.; Langin, D. and Fajas, L. (2009) CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. Cell Metab., 9, 339-349.
79. Chavey, C. and Fajas, L. (2009) CXCL5 drives obesity to diabetes, and further. Aging (Albany NY). 1, 674-677.
80. Lehrke, M. and Lazar, M.A. (2005) The many faces of PPARγ. Cell, 123, 993-999.
81. Choi, J.H.; Banks, A.S.; Estall, J.L.; Kajimura, S.; Boström, P.; Laznik, D.; Ruas, J.L.; Chalmers, M.J.; Kamenecka, T.M.; Blüher, M; Griffin, P.R. and Spiegelman, B.M. (2010) Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5. Nature, 466, 451-456.
82. Siersbaek, R.; Nielsen, R. and Mandrup, S. (2010) PPARγ in adipocyte differentiation and metabolism--novel insights from genome-wide studies. FEBS Lett., 584, 3242-3249.
83. Gavrilova, O.; Haluzik, M.; Matsusue, K.; Cutson, J.J.; Johnson, L.; Dietz, K.R.; Nicol, C.J.; Vinson, C.; Gonzalez, F.J. and Reitman, M.L. (2003) Liver peroxisome proliferator-activated receptorγ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J. Biol. Chem., 278, 34268-34276.
84. Suganami, T. and Ogawa, Y. (2010) Adipose tissue macrophages: their role in adipose tissue remodeling. J. Leukoc. Biol., 88, 33-39.
85. Cusi, K. (2010) The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr. Diab. Rep., 10, 306-315.
86. Jeong, H.W.; Lee, J.W.; Kim, W.S.; Choe, S.S.; Shin, H.J.; Lee, G.Y.; Shin, D.; Lee, J.H.; Choi, E.B.; Lee, H.K.; Yon, G.H.; Cho, B.; Kim, H.R.; Choi, S.H.; Chung, Y.S.; Park, S.B.; Chung, H.; Ro, S. and Kim, J.B. (2010) A non-TZD PPARα/γ dual agonist CG301360 alleviates insulin resistance and lipid dysregulation in db/db mice. Mol. Pharmacol., [Epub ahead of print].
87. Ricote, M.; Li, A.C.; Willson, T.M.; Kelly, C.J. and Glass, C.K. (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature, 391, 79-82.
88. Pascual, G.; Fong, A.L.; Ogawa, S.; Gamliel, A.; Li, A.C.; Perissi, V.; Rose, D.W.; Willson, T.M.; Rosenfeld, M.G. and Glass, C.K. (2005) A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature, 437, 759-763.
89. Charrière, G.; Cousin, B.; Arnaud, E.; André, M.; Bacou, F.; Penicaud, L. and Casteilla, L. (2003) Preadipocyte conversion to macrophage. Evidence of plasticity. J. Biol. Chem., 278, 9850-9855.
90. University of Virginia study shows that Lisofylline reduces obesity-related inflammation and insulin resistance. http://www.drugs.com/clinical_trials/university-virginia-study-shows-lisofyllinereduces-obesity-related-inflammation-insulin-resistance-3977.html (Accessed September 25, 2010)
91. Nishimura, S.; Manabe, I.; Nagasaki, M.; Eto, K.; Yamashita, H.; Ohsugi, M.; Otsu, M.; Hara, K.; Ueki, K.; Sugiura, S.; Yoshimura, K.; Kadowaki, T. and Nagai, R. (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med., 15, 914-920.
92. Winer, S.; Chan, Y.; Paltser, G.; Truong, D.; Tsui, H.; Bahrami, J.; Dorfman, R.; Wang, Y.; Zielenski, J.; Mastronardi, F.; Maezawa, Y.; Drucker, D.J.; Engleman, E.; Winer, D. and Dosch, H.M. (2009) Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med., 15, 921-929.
93. Tritt, M.; Sgouroudis, E.; d'Hennezel, E.; Albanese, A. and Piccirillo, C.A. (2008) Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes, 57, 113-123.
94. Nair, S.; Ramaswamy, P.A.; Ghosh, S.; Joshi, D.C.; Pathak, N.; Siddiqui, I.; Sharma, P.; Hasnain, S.E.; Mande, S.C. and Mukhopadhyay, S. (2009) The PPE18 of Mycobacterium tuberculosis interacts with TLR2 and activates IL-10 induction in macrophage. J. Immunol., 183, 6269-6281.
95. Alam, K.; Ghousunnissa, S.; Nair, S.; Valluri, V.L. and Mukhopadhyay, S. (2010) Glutathione-redox balance regulates crel- driven IL-12 production in macrophages: possible implications in anti-tuberculosis immunotherapy. J. Immunol., 184, 2918-2929.
96. Wright, E. Jr.; Scism-Bacon, J.L. and Glass, L.C. (2006) Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int. J. Clin. Pract., 60, 308-314.
97. Pitocco, D.; Zaccardi, F.; Di Stasio, E.; Romitelli, F.; Santini, S.A.; Zuppi, C. and Ghirlanda, G. (2010) Oxidative stress, nitric oxide, and diabetes. Rev. Diabet. Stud., 7, 15-25.